Daxor Showcases Blood Volume Analyzer at MedAxiom CV Transforum

Daxor will attend MedAxiom's CV Transforum Fall '26 in Denver, Colorado, October 22-24, 2026. Commercial leaders will demonstrate the FDA-cleared next-generation Blood Volume Analyzer platform to cardiovascular executives, focusing on clinical integration and institutional returns. The platform operates three times faster than its predecessor, requires 50% less sample volume and delivers greater than 95% measurement accuracy. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daxor Corporation published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein. (C)